Donley Matthew Maxwell
SEC insider (Form 3/4/5 filer). CIK 0001636642. Chief Operating Officer at Aurinia Pharmaceuticals Inc. (AUPH). 9 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in EDMONTON, A0.
Companies Donley Matthew Maxwell has filed insider reports for
- Aurinia Pharmaceuticals Inc. (AUPH): Officer, Chief Operating Officer
Donley Matthew Maxwell
CIK: 0001636642
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aurinia Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Mar 2, 2026AUPH
Aurinia Pharmaceuticals Inc.
Tax PaymentDirect40.8K shares at avg. $14.21$579K - Feb 27, 2026AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect58.2K shares- - Feb 20, 2026AUPH
Aurinia Pharmaceuticals Inc.
Tax PaymentDirect32.9K shares at avg. $14.40$474K - Jan 2, 2026AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect54.2K shares- - Jan 2, 2026AUPH
Aurinia Pharmaceuticals Inc.
Tax PaymentDirect42.8K shares at avg. $15.95$682K - Mar 4, 2025AUPH
Aurinia Pharmaceuticals Inc.
SaleDirect59K shares at avg. $7.92$467K - Mar 3, 2025AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect135.6K shares- - Mar 3, 2025AUPH
Aurinia Pharmaceuticals Inc.
SaleDirect65.9K shares at avg. $8.00$527K - Feb 28, 2025AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect82.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Tax Payment | 40,761 | $14.21 | $579,214 | Direct |
| Feb 27, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Award | 58,160 | - | $0 | Direct |
| Feb 20, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Tax Payment | 32,901 | $14.40 | $473,774 | Direct |
| Jan 2, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Award | 54,166 | - | $0 | Direct |
| Jan 2, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Tax Payment | 42,787 | $15.95 | $682,453 | Direct |
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Sale | 58,991 | $7.92 | $467,209 | Direct |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Award | 135,567 | - | - | Direct |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Sale | 65,902 | $8.00 | $527,216 | Direct |
| Feb 28, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Award | 82,781 | - | - | Direct |
1-9 of 9 transactions